MAP1B risk_factor_for Alzheimer's disease
Evidence from:
primary |
all sources
Evidence (1 sources)
Integrative transcriptome analyses of the aging brain implicate altered splicing in Alzheimer's disease susceptibility.
(2018)
PMID:30297968
cited
new Alzheimer’s disease genes ... include MAP1B ... now significant at a threshold adjusted for genome-wide testing
confidence: 0.95